October 07, 2025
Oct. 7, 2025 — Nobles Medical Technology II, a provider of  cardiovascular closure solutions, has announced that the U.…
October 03, 2025
Oct. 2, 2025 — AorticLab recently announced the U.S. Food and Drug Administration (FDA) has approved its…
October 03, 2025
Sept. 26, 2025 — A new guideline from the American Society of Echocardiography (ASE) offers updated and expanded…
October 02, 2025
Oct. 1, 2025 – Intelerad has announced the next generation of InteleHeart, a reimagined, all-in-one cardiology platform…
October 02, 2025
Hypertension remains the leading modifiable driver of cardiovascular disease and premature death.1 Even with multiple…
October 02, 2025
Sept. 30, 2025 — Biograph and Caristo Diagnostics have announced a partnership for Biograph to become the first U.S.…
September 30, 2025
Sept. 29, 2025 — Many studies have shown the inverse relationship between bone mineral density (BMD) — the gold…
September 30, 2025
Sept. 30, 2025 — Cleerly has announced that coverage policies from UnitedHealthcare and Cigna for Cleerly LABS advanced…
September 30, 2025
Sept. 29, 2025 — Radiation therapy may offer a comparable and potentially safer alternative to repeat catheter ablation…
September 29, 2025
Sept. 29, 2025 — AngioSafe has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its…
September 25, 2025
Sept. 25, 2025 — Royal Philips has entered a national partnership in the United States with Optum Healthcare. The…
September 25, 2025
Sept. 25, 2025 — Kardigan has introduced the three late-stage clinical programs leading its robust pipeline, each…
September 24, 2025
Sept. 24, 2025 — The Family Heart Foundation, a leading research and advocacy organization, has announced the online…
September 24, 2025
Sept. 23, 2025 — Ultromics, a pioneer in AI-driven cardiology solutions, has announced findings from its new study on…
September 23, 2025
Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent…
September 23, 2025
Sept. 23, 2025 — CeleCor Therapeutics’ multinational Phase 3 clinical trial of its investigational heart-attack drug…
September 23, 2025
Sept. 22, 2025 — Heartflow, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Next Gen…
September 22, 2025
Sept. 22, 2025 — The latest findings on heart failure (HF) published by the Heart Failure Society of America (HFSA)…
September 22, 2025
Sept. 18, 2025 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI), American Society of Nuclear Cardiology…
September 19, 2025
Sept. 18, 2025 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and…
